- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Valhi Outperforms Kiwa Bio-Tech in Basic Materials Sector
Contrasting the financial performance and competitive advantages of two publicly traded basic materials companies
Published on Feb. 13, 2026
Got story updates? Submit your updates here. ›
Valhi (NYSE:VHI) and Kiwa Bio-Tech Products Group (OTCMKTS:KWBT) are both basic materials companies, but an analysis shows that Valhi is the superior stock. The report compares the two companies across key metrics like profitability, institutional ownership, earnings, and analyst recommendations, finding that Valhi outperforms Kiwa Bio-Tech on most measures.
Why it matters
This comparison is relevant for investors looking to allocate capital in the basic materials sector, as it highlights the relative strengths and weaknesses of two publicly traded players in this space. Understanding the competitive dynamics can help inform investment decisions.
The details
Valhi has higher net margins, return on equity, and return on assets compared to Kiwa Bio-Tech. Valhi also has stronger institutional ownership at 3.8% versus just 1.3% for Kiwa Bio-Tech. Additionally, Valhi generates higher revenue and earnings than its competitor. Analysts also rate Valhi more favorably, with a consensus target price indicating potential upside, while seeing downside risk for Kiwa Bio-Tech.
- The analysis is based on the latest financial data as of February 13, 2026.
The players
Valhi, Inc.
A diversified holding company with businesses in chemicals, component products, and real estate management and development.
Kiwa Bio-Tech Products Group Corporation
A Chinese company that develops, manufactures, and distributes bio-technological products for the agricultural market.
The takeaway
This analysis highlights Valhi's competitive advantages over Kiwa Bio-Tech in the basic materials sector, making it the more favorable investment option based on the metrics examined. Investors should continue to monitor the performance and strategic positioning of both companies as they navigate the evolving market dynamics.
Dallas top stories
Dallas events
Feb. 17, 2026
ClippingFeb. 17, 2026
The Great Gatsby (Touring)




